Merck KGaA (ETR:MRK) Stock Price Down 3.1% – Should You Sell?

Merck KGaA (ETR:MRKGet Free Report) shares traded down 3.1% during mid-day trading on Friday . The stock traded as low as €121.60 ($133.63) and last traded at €122.20 ($134.29). 473,666 shares traded hands during mid-day trading, The stock had previously closed at €126.10 ($138.57).

Merck KGaA Stock Performance

The company’s fifty day simple moving average is €136.24 and its two-hundred day simple moving average is €144.19. The company has a market capitalization of $54.42 billion, a price-to-earnings ratio of 20.07, a price-to-earnings-growth ratio of 2.37 and a beta of 0.71.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Featured Articles

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.